| Authors: |
Ramón-García S; Department of Microbiology, Pediatrics, Radiology and Public Health, Faculty of Medicine, University of Zaragoza, Zaragoza, Spain; Research & Development Agency of Aragón Foundation (Fundación ARAID), Zaragoza, Spain; Department of Microbiology and Immunology, Life Sciences Centre, University of British Columbia, Vancouver, BC, Canada. Electronic address: santiramon@unizar.es., González Del Río R; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Arenaz-Callao MP; Research & Development Agency of Aragón Foundation (Fundación ARAID), Zaragoza, Spain; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Boshoff HI; Tuberculosis Research Section, NIH, Bethesda, USA., Rullas J; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Anca S; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Cacho Izquierdo M; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Porras de Francisco E; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Pérez Herrán E; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Santos-Villarejo A; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Mendoza-Losana A; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Ferrer-Bazaga S; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Thompson CJ; Department of Microbiology and Immunology, Life Sciences Centre, University of British Columbia, Vancouver, BC, Canada., Barros Aguirre D; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Bates RH; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain. Electronic address: robert.h.bates@gsk.com. |
